Skip to main content
Top
Published in: Pediatric Rheumatology 1/2014

Open Access 01-12-2014 | Research

Assessment of musculoskeletal abnormalities in children with mucopolysaccharidoses using pGALS

Authors: Mercedes O Chan, Ethan S Sen, Elizabeth Hardy, Pauline Hensman, Edmond Wraith, Simon Jones, Tim Rapley, Helen E Foster

Published in: Pediatric Rheumatology | Issue 1/2014

Login to get access

Abstract

Background

Children with mucopolysaccharidoses (MPS) often have musculoskeletal (MSK) abnormalities. Paediatric Gait, Arms, Legs, and Spine (pGALS), is a simple MSK assessment validated in school-age children to detect abnormal joints. We aimed to identify MSK abnormalities in children with MPS performing pGALS.

Methods

Videos of children with a spectrum of MPS performing pGALS were analysed. A piloted proforma to record abnormalities for each pGALS manoeuvre observed in the videos (scored as normal/abnormal/not assessable) was used by three observers blinded to MPS subtype. Videos were scored independently and rescored for intra- and inter-observer consistency. Data were pooled and analysed.

Results

Eighteen videos of children [12 boys, 6 girls, median age 11 years (4–19)] with MPS (13 type I [5 Hurler, 8 attenuated type I]; 4 type II; 1 mannosidosis) were assessed. The most common abnormalities detected using pGALS were restrictions of the shoulder, elbow, wrist, jaw (>75% cases), and fingers (2/3 cases). Mean intra-observer Κ 0.74 (range 0.65–0.88) and inter-observer Κ 0.62 (range 0.51–0.77). Hip manoeuvres were not clearly demonstrated in the videos.

Conclusions

In this observational study, pGALS identifies MSK abnormalities in children with MPS. Restricted joint movement (especially upper limb) was a consistent finding. Future work includes pGALS assessment of the hip and testing pGALS in further children with attenuated MPS type I. The use of pGALS and awareness of patterns of joint involvement may be a useful adjunct to facilitate earlier recognition of these rare conditions and ultimately access to specialist care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Muenzer J: Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011, 50 (Suppl 5): 4-12.CrossRef Muenzer J: Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011, 50 (Suppl 5): 4-12.CrossRef
2.
go back to reference Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF: Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr. 2004, 144 (5): 581-588.CrossRefPubMed Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF: Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr. 2004, 144 (5): 581-588.CrossRefPubMed
3.
go back to reference Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, Izykowski B, Phillips J, Doroshow R, Walot I, Hoft R, Neufeld EF: Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med. 2001, 344 (3): 182-188.CrossRefPubMed Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, Izykowski B, Phillips J, Doroshow R, Walot I, Hoft R, Neufeld EF: Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med. 2001, 344 (3): 182-188.CrossRefPubMed
4.
go back to reference Clarke LA, Wraith JE, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Sidman M, Kakkis ED, Cox GF: Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics. 2009, 123 (1): 229-240.CrossRefPubMed Clarke LA, Wraith JE, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Sidman M, Kakkis ED, Cox GF: Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics. 2009, 123 (1): 229-240.CrossRefPubMed
5.
go back to reference Morishita K, Petty RE: Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology (Oxford). 2011, 50 (Suppl 5): 19-25.CrossRef Morishita K, Petty RE: Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology (Oxford). 2011, 50 (Suppl 5): 19-25.CrossRef
6.
go back to reference Vijay S, Wraith JE: Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr. 2005, 94: 872-877.CrossRefPubMed Vijay S, Wraith JE: Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr. 2005, 94: 872-877.CrossRefPubMed
7.
go back to reference Foster HE, Kay LJ, Friswell M, Coady D, Myers A: Musculoskeletal screening examination (pGALS) for school-age children based on the adult GALS screen. Arthritis Rheum. 2006, 55: 709-716.CrossRefPubMed Foster HE, Kay LJ, Friswell M, Coady D, Myers A: Musculoskeletal screening examination (pGALS) for school-age children based on the adult GALS screen. Arthritis Rheum. 2006, 55: 709-716.CrossRefPubMed
9.
go back to reference Foster H, Kay L, May C, Rapley T: Pediatric regional examination of the musculoskeletal system: A practice- and consensus-based approach. Arthritis Care Res (Hoboken). 2011, 63: 1503-1510.CrossRef Foster H, Kay L, May C, Rapley T: Pediatric regional examination of the musculoskeletal system: A practice- and consensus-based approach. Arthritis Care Res (Hoboken). 2011, 63: 1503-1510.CrossRef
11.
go back to reference Cimaz R, Vijay S, Haase C, Coppa GV, Bruni S, Wraith E, Guffon N: Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: A series of 13 patients with Scheie syndrome. Clin Exp Rheumatol. 2006, 24 (2): 196-202.PubMed Cimaz R, Vijay S, Haase C, Coppa GV, Bruni S, Wraith E, Guffon N: Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: A series of 13 patients with Scheie syndrome. Clin Exp Rheumatol. 2006, 24 (2): 196-202.PubMed
12.
go back to reference Sifuentes M, Doroshow R, Hoft R, Mason G, Walot I, Diament M, Okazaki S, Huff K, Cox GF, Swiedler SJ, Kakkis ED: A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab. 2007, 90 (2): 171-180.CrossRefPubMed Sifuentes M, Doroshow R, Hoft R, Mason G, Walot I, Diament M, Okazaki S, Huff K, Cox GF, Swiedler SJ, Kakkis ED: A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab. 2007, 90 (2): 171-180.CrossRefPubMed
13.
go back to reference McGovern E, Owens L, Nunn J, Bolas A, Meara AO, Fleming P: Oral features and dental health in Hurler syndrome following hematopoietic stem cell transplantation. Int J Paediatr Dent. 2010, 20: 322-329.CrossRefPubMed McGovern E, Owens L, Nunn J, Bolas A, Meara AO, Fleming P: Oral features and dental health in Hurler syndrome following hematopoietic stem cell transplantation. Int J Paediatr Dent. 2010, 20: 322-329.CrossRefPubMed
14.
go back to reference Goff I, Bateman B, Myers A, Foster H: Acceptability and practicality of musculoskeletal examination in acute general pediatric assessment. J Pediatr. 2010, 156: 657-662.CrossRefPubMed Goff I, Bateman B, Myers A, Foster H: Acceptability and practicality of musculoskeletal examination in acute general pediatric assessment. J Pediatr. 2010, 156: 657-662.CrossRefPubMed
15.
go back to reference Smith E, Molyneux E, Heikens GT, Foster H: Acceptability and practicality of pGALS in screening for rheumatic disease in malawian children. Clin Rheumatol. 2012, 31: 647-653.CrossRefPubMed Smith E, Molyneux E, Heikens GT, Foster H: Acceptability and practicality of pGALS in screening for rheumatic disease in malawian children. Clin Rheumatol. 2012, 31: 647-653.CrossRefPubMed
16.
go back to reference Goff I, Rowan A, Bateman BJ, Foster HE: Poor sensitivity of musculoskeletal history in children. Arch Dis Child. 2012, 97: 644-646.CrossRefPubMed Goff I, Rowan A, Bateman BJ, Foster HE: Poor sensitivity of musculoskeletal history in children. Arch Dis Child. 2012, 97: 644-646.CrossRefPubMed
17.
go back to reference Cimaz R, Coppa GV, Kone-Paut I, Link B, Pastores GM, Elorduy MR, Spencer C, Thorne C, Wulffraat N, Manger B: Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J. 2009, 7: 18-0096-7-18-CrossRef Cimaz R, Coppa GV, Kone-Paut I, Link B, Pastores GM, Elorduy MR, Spencer C, Thorne C, Wulffraat N, Manger B: Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J. 2009, 7: 18-0096-7-18-CrossRef
Metadata
Title
Assessment of musculoskeletal abnormalities in children with mucopolysaccharidoses using pGALS
Authors
Mercedes O Chan
Ethan S Sen
Elizabeth Hardy
Pauline Hensman
Edmond Wraith
Simon Jones
Tim Rapley
Helen E Foster
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2014
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-12-32

Other articles of this Issue 1/2014

Pediatric Rheumatology 1/2014 Go to the issue